Mutation of Threonine 766 in the Epidermal Growth Factor Receptor Reveals a Hotspot for Resistance Formation against Selective Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Mutation of Threonine 766 in the Epidermal Growth Factor Receptor Reveals a Hotspot for Resistance Formation against Selective Tyrosine Kinase Inhibitors

Published:2003-04 Issue:17 Volume:278 Page:15435-15440
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Blencke Stephanie,Ullrich Axel,Daub Henrik

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference28 articles.

1. Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways

2. Vertebrate non-receptor protein-tyrosine kinase families

3. Receptor tyrosine kinase signalling as a target for cancer intervention strategies.

4. Rational therapeutic intervention in cancer: kinases as drug targets

5. STI571 (Gleevec™) as a paradigm for cancer therapy

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Different Mechanisms Involved in Cancer Drug Resistance;Multi‐Drug Resistance in Cancer;2023-07-17

2. Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives as novel anti-cancer, dual EGFR^WT/COX-2 inhibitors with docking studies;RSC Advances;2023

3. Genetic alterations shaping tumor response to anti-EGFR therapies;Drug Resistance Updates;2022-09

4. Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach;Computers in Biology and Medicine;2022-02

5. Emerging Role of Structural and Systems Biology in Anticancer Therapeutics;Systems Biomedicine Approaches in Cancer Research;2022